Fraunhofer Health

Health research at Fraunhofer addresses the four key areas of medical science — drugs, diagnostics, devices and data, or 4D for short. Many innovations emerge at the interface between medical science, natural science, computer science and engineering. With its emphasis on transdisciplinary research, the Fraunhofer-Gesellschaft offers the perfect environment for close collaboration on health research and the development of cost-intelligent precision medicine for the benefit of patients.



Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM

New Opportunity for Cancer Therapy: Miniature Lab Provides Insights into Metastases Development

Every year, around half a million people in Germany are diagnosed with cancer. Despite the existence of effective treatment options for many types of cancer, many questions about the development of the disease remain unanswered. Why does a tumor develop? What factors promote the growth of cancer cells? Why do metastases spread to other organs over time? 


Fraunhofer-Institut für Zelltherapie und Immunologie IZI

Tumorgewebe auf dem Chip: Neue Möglichkeiten für Zelltherapien und personalisierte Medizin

Wie reagiert ein Tumor auf eine bestimmte Therapie? Dies bereits vor Beginn der Therapie zu wissen, wäre für Krebskranke und die behandelnden Ärztinnen und Ärzte von großem Wert. Für die vielversprechende CAR-T-Zelltherapie haben Forschende des Universitätsklinikums Würzburg (UKW), des Fraunhofer Instituts für Zelltherapie und Immunologie mit seiner Außenstelle Würzburg und des Universitätsklinikums Tübingen nun genau diese Beobachtung möglich gemacht – in Echtzeit und am Tumorgewebe der Erkrankten.


Fraunhofer Institute for Digital Medicine MEVIS

MRI measurements on a desk

Fraunhofer MEVIS aims for utilizing compact MRI devices for research and education. Magnetic resonance imaging (MRI) provides non-invasive insights into the human body. This is why MRI scanners are an integral part of routine diagnostic imaging. However, their programming is complex and requires highly specialized knowledge. An initiative by the Fraunhofer Institute for Digital Medicine MEVIS in Bremen now tries to change this: Fraunhofer MEVIS has purchased several small tabletop MRI devices to be combined with the in-house developed software platform gammaSTAR. 


Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

The virus hackers - RNAi therapy for viral respiratory diseases

A research team from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and the Hannover Medical School (MHH) have made significant progress in developing a new antiviral therapy. The drug, which is inhaled, uses RNAi to target and deactivate parainfluenza viruses before they multiply.


Fraunhofer Institute for Biomedical Engineering IBMT

Network of young scientists for research into a combinatorial diagnostics of Alzheimer’s disease

Fraunhofer IBMT Partner in the EU-Project »CombiDiag«. Memory impairment, orientation problems and speech difficulties can be signs of the onset of Alzheimer's dementia. This disease is not yet curable, but its progression can be slowed down with medication and supportive measures. The EU project "CombiDiag" is a doctoral network funded under the Marie Skłodowska-Curie actions of Horizon Europe, aiming to train ten doctoral students in the field of multimodal peripheral markers and their combinatorial use for the diagnosis of early-stage Alzheimer's disease (AD). 


Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

EU project REGENERAR: 3 million euros allocated for research into the development of innovative technologies for brain regeneration

With the aim of developing a new technology for brain regeneration, the EU project REGENERAR kicks off on March 22, 2024. Fraunhofer ITEM is one of seven research partners, led by the University of Coimbra, seeking to create better therapies for patients with neurodegenerative diseases or stroke using this technology.


DFKI | Fraunhofer Institute for Digital Medicine MEVIS

Enhanced diagnostic precision through improved imaging

How researchers from Bremen pave the way for Artificial Intelligence in Magnetic Resonance Imaging. Magnetic Resonance Imaging (MRI) is considered the most versatile and flexible imaging technique in medical diagnostics. Using radiofrequency pulses and magnetic fields, it enables the creation of detailed cross-sectional images of the human body, allowing for a thorough assessment of organs and pathological organ changes. The quality of these images depends largely on the selected setting, referred to as the MRI sequence.


Fraunhofer Institute for Biomedical Engineering IBMT

Development of a miniaturized lung and kidney support device for critically ill newborns

The EU project "ArtPlac" is a preclinical research project to develop an innovative technology for medical treatments in neonatal intensive care. The project involves an international research team of physicians and engineers, supported by an organization that represents the interests of premature and newborn babies and their families. 


Research consortium CureMILS | Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

»Restart« for energy metabolism - hope for people with rare disease

Der Einsatz bereits zugelassener Medikamente lässt auf neue Wege zur Behandlung seltener Erkrankungen wie des Leigh-Syndroms hoffen. Dies zeigen die Arbeiten im Forschungskonsortium CureMILS, die zu ersten erfolgreichen Behandlungen führten.


Joint project »CAR Factory« | Fraunhofer Institute for Cell Therapy and Immunology IZI

»CAR Factory«: New approaches in immune cell therapy

Deutsche Krebshilfe fördert deutschlandweites Forschungsnetzwerk zur CAR-Zell-Therapie mit 4 Millionen Euro. Das Verbundprojekt »CAR Factory« wird von Professor Dr. Michael Hudecek (Universitätsklinikum Würzburg, UKW) und Professorin Dr. Evelyn Ullrich (Universitätsklinikum Frankfurt am Main) geleitet.


Fraunhofer Institute for Biomedical Engineering IBMT

Bidirectional control of prosthetic hands using ultrasonic sensors

For anyone who has lost a hand, a functional prosthetic hand is of enormous benefit when it comes to everyday activities. So researchers at Fraunhofer are working as part of an EU research project to improve control of prosthetic hands down to individual fingers. Instead of conventional electrodes that detect nerve impulses in muscle tissue in the arm, these rely on ultrasonic sensors. This means commands can be executed with far greater accuracy and sensitivity. In the next stage, researchers want to make the design bidirec-tional, with the brain also receiving sensory stimuli from the prosthesis.


Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Fraunhofer, DESY, Hereon and EMBL sign MoU for closer collaboration.

Fraunhofer ITMP participates in the health area and already brought this cooperation to life with the »Fraunhofer at DESY: Focus on BioMed« workshop on November 9th 2023. The joint proposal on »The role of antibiotic influx and efflux in antimicrobial resistance of Gram-negative bacteria« from ITMP (experiment design, probes), IAP-CAN (nanoparticle markers) and DESY (imaging) has been awarded as one of the pilot projects.


Fraunhofer Institute for Digital Medicine MEVIS

Bremen AI in Health conference: science, business and politics exchanged ideas on AI and health research

More than 150 stakeholders from science, business and politics met at the Bremen AI in Health conference on September, 21 2023 to discuss artificial intelligence and health research.


Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Topping-out ceremony of the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP


Fraunhofer Match − a fast solution

Do you have a research request?

Fraunhofer Match is the central platform for placing research requests with Fraunhofer. You tell us about your challenge or project − and Fraunhofer Match will put you in touch with researchers who have the right expertise to help you work out solutions.



News Archive

Further notifications from our member institutes